Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update
References (181)
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability
J Affect Disord
(2000)- et al.
What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials
Eur Neuropsychopharmacol
(2007) - et al.
Pharmacokinetics of selective serotonin reuptake inhibitors
Pharmacol Ther
(2000) Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species
Chem Biol Interact
(1997)Pharmacogenetics and adverse drug reactions
Lancet
(2000)- et al.
Interaction of metoprolol and fluoxetine
Lancet
(1993) - et al.
Heart block in a patient on propranolol and fluoxetine
Lancet
(1994) - et al.
No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin
Epilepsy Res
(1991) - et al.
Fluvoxamine is a potent inhibitor of cytochrome P4501A2
Biochem Pharmacol
(1993) - et al.
Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia
Pharmacol Res
(2005)
Depression: Management of Depression in Primary and Secondary Care
Clinical Guideline 23
(2004)
Prevalence and management of treatmentresistant depression
J Clin Psychiatry
(2007)
Newer and older antidepressants: A comparative review of drug interactions
CNS Drugs
(1994)
Newer antidepressants and the cytochrome P450 system
Am J Psychiatry
(1996)
Pharmacokinetic drug interaction potential of selective serotonin reuptake inhibitors [published correction appears in Int Clin Psychopharmacol. 1997;12:126]
Int Clin Psychopharmacol
(1996)
Drug interactions with newer antidepressants: Role of human cytochromes P450
J Clin Psychiatry
(1998)
Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: An update
Curr Drug Metab
(2002)
Metabolic drug interactions with new psychotropic agents
Fundam Clin Pharmacol
(2003)
P450 Superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
Pharmacogenetics
(1996)
Inhibition and induction of cytochrome P450 and the clinical implications
Clin Pharmacokinet
(1998)
Metabolically-based drug-drug interactions: Principles and mechanisms
Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence
Clin Pharmacokinet
(1997)
The AGNP-TDM expert group consensus guidelines: Therapeutic drug monitoring in psychiatry
Pharmacopsychiatry
(2004)
Clinically significant drug interactions with antidepressants in the elderly
Drugs & Aging
(2002)
Antidepressants
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes
Br J Clin Pharmacol
(1992)
Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: Studies of phenytoin p-hydroxylaton
Br J Clin Pharmacol
(1997)
The effects of selective serotonin reuptake inhibitors and their metabolites on S-mephenytoin 4'-hydroxylase activity in human liver microsomes
Br J Clin Pharmacol
(1995)
Inhibition of human cytochrome P450-3A isoforms by fluoxetine and norfluoxetine: In vitro and in vivo studies
J Clin Pharmacol
(1996)
Elevated antidepressant plasma levels after addition of fluoxetine
Am J Psychiatry
(1989)
Fluoxetine-induced tricyclic toxicity: Extent and duration
J Clin Pharmacol
(1991)
Quantification and mechanism of the fluoxetine and tricyclic antidepressaant interaction
Clin Pharmacol Ther
(1992)
Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine
J Clin Psychopharmacol
(1994)
Interaction between fluoxetine and haloperidol: Pharmacokinetic and clinical implications
Pharmacol Res
(1997)
Serum concentrations of clozapine and its major metabolites: Effects of cotreatment with fluoxetine or valproate
Am J Psychiatry
(1994)
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors
Am J Psychiatry
(1996)
Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia
Int Clin Psycho pharmacol
(1998)
Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: A clinically relevant pharmacokinetic drug interaction
J Clin Psychopharmacol
(2002)
The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients
Pharmacopsychiatry
(2002)
Influence of fluoxetine on olanzapine pharmacokinetics
AAPS PharmSci
(2002)
Effect of fluoxetine and imipramine on the pharmacokinetics and tolerabilitty of the antipsychotic quetiapine
J Clin Psychopharmacol
(2002)
Metabolic drug interactions with newer antipsychotics: A comparative review
Basic Clin Pharmacol Toxicol
(2007)
The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam
Clin Pharmacol Ther
(1988)
Fluoxetine impairs clearance of alprazolam but not of clonazepam
Clin Pharmacol Ther
(1992)
Interaction of fluoxetine with carbamazepine
J Clin Psychiatry
(1990)
Increased carbamazepine plasma concentrations after fluoxetine coadministration
Clin Pharmacol Ther
(1991)
Carbamazepine coadministration with fluoxetine or fluvoxamine
Ther Drug Monit
(1993)
Toxic reaction following the combined administration of fluoxetine and phenytoin: Two case reports
J Neurol Neurosurg Psychiatry
(1992)
Interaction of phenytoin and fluoxetine [2]
NZ Med J
(1994)
Cited by (300)
Tratamiento complementario/combinado de la depresión en ratas: aloe vera, fluoxetina y acupuntura. Un estudio experimental
2023, Revista Internacional de AcupunturaPre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine
2022, Current Research in Pharmacology and Drug DiscoveryPharmacogenomics in bipolar disorder: Towards precision psychiatry and personalized treatment
2022, Biomarkers in Bipolar DisordersThe link between neurology and behavior in veterinary medicine: A review
2021, Journal of Veterinary Behavior
Copyright © 2008 Published by Elsevier Inc.